| 发明名称 |
NOVEL COMPOUNDS |
| 摘要 |
The invention relates to spiro derivatives, to the use of said derivatives intreating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation. |
| 申请公布号 |
US2015166551(A1) |
申请公布日期 |
2015.06.18 |
| 申请号 |
US201314403473 |
申请日期 |
2013.05.22 |
| 申请人 |
CONVERGENCE PHARMACEUTICALS LIMITED |
发明人 |
Giblin Gerard M.P.;Macpherson David T.;Witty David R.;Stanway Steven J. |
| 分类号 |
C07D487/10 |
主分类号 |
C07D487/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1: A compound of formula (I) which is 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]nonan-6-one:or a pharmaceutically acceptable salt or solvate thereof. |
| 地址 |
Cambridge GB |
